Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lawrence Steinman currently holds 199,691 shares of BioAtla, Inc. (BCAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence Steinman has been a net buyer of BCAB stock. They have purchased $197.4K and sold $65.6K worth of shares.
Lawrence Steinman's most recent insider trade was on Nov 28, 2025, when they purchased 133,333 shares at $0.75 per share.
Lawrence Steinman serves as Executive at BioAtla, Inc. (BCAB). They have executed 26 insider transactions totaling $263.0K over their tenure at the company.
Lawrence Steinman holds the position of Executive at BioAtla, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Lawrence Steinman has shown a buying trading pattern, with $197.4K in total purchases and $65.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Lawrence Steinman was on Apr 7, 2021, when they purchased $138.7K worth of ATNF shares. This transaction involved 22,585 shares at $6.14 per share.
Lawrence Steinman currently owns 199,691 shares of BioAtla, Inc. (BCAB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lawrence Steinman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lawrence Steinman has 26 Form 4 filings on record as an insider at BioAtla, Inc..
Set alerts for Lawrence Steinman and 40,000+ other insiders.